Revance Therapeutics Inc Stock Price. Everything You Need To Know About The Revance Therapeutics Inc Stock! Revance Therapeutics Inc Stock Price. Everything You Need To Know About The Revance Therapeutics Inc Stock!


Revance Therapeutics, Inc. is a biotech company based in Nashville, Tennessee, focused on the development and commercialization of botulinum toxin products for therapeutic and aesthetic purposes. The company’s lead product is DaxibotulinumtoxinA for Injection, a neuromodulator product used for treating various conditions, including upper limb spasticity, glabellar lines, forehead lines, and crow’s feet. The product is unique in that it combines a stabilizing peptide excipient with a purified botulinum toxin, which does not contain human or animal-based components.

Revance Therapeutics is also involved in developing additional aesthetic and therapeutic indications for DaxibotulinumtoxinA for Injection. The company offers resilient hyaluronic acid (RHA) Collection of dermal fillers and OPUL, a point-of-sale platform, software, and hardware terminal for United States aesthetics practices.

As a clinical stage biotechnology company, Revance Therapeutics operates in a dynamic and ever-changing industry. Therefore, staying up-to-date with the latest developments and trends is essential for investors looking to invest in the stock market. Doing thorough research on the stock market, and monitoring the stock price today and premarket, can help investors make informed decisions.

By focusing on developing innovative and advanced products, Revance Therapeutics is well-positioned to capture a significant market share in the aesthetic and therapeutic botulinum toxin products market. Therefore, it is worth keeping an eye on this company and its future growth potential.



Revance Therapeutics Inc Stock Price. Everything You Need To Know About The Revance Therapeutics Inc Stock! performance

  • Employees 534
  • Company HQ Nashville
  • Website https://www.revance.com/
  • RVNC Asset Type Common Stock
  • RVNC Market Capitalization 292.5M
  • Earnings Per Share -3.77
  • Dividends Per Share None
  • Dividend Date None
  • Quarterly Earnings Growth 0

If you’re a retail investor from Malaysia, Thailand, Indonesia, or Vietnam looking to invest in the stock market, Revance Therapeutics is a stock you should consider. As a content marketing expert at Zorion, an investment platform offering real US stock and Pre-IPO company investments, I can provide you with valuable insights on how to invest in this promising stock. Revance Therapeutics, a biotechnology company, is focused on developing innovative aesthetic and therapeutic products. With our investment recommendations and resources, we can help you make informed decisions about investing in Revance Therapeutics and expand your investment knowledge. Invest wisely and stay ahead of the game.


Want To Buy Revance Therapeutics Inc Stock From Malaysia, Indonesia, Thailand or Philippines? You may also be interested in: